sechenovSechenov Medical JournalСеченовский вестник2218-73322658-3348Сеченовский Университет10.47093/2218-7332.2020.11.2.62-73sechenov-242Research ArticleCOVID-19COVID-19Features of the management of cancer patients during the COVID-19 pandemicОсобенности ведения онкологических пациентов во время пандемии коронавирусной инфекции COVID-19https://orcid.org/0000-0003-0015-7094СекачеваМ. И.SekachevaM. I.

Секачева Марина Игоревна, д-р мед. наук, профессор, директор Института персонализированной медицины, руководитель Центра персонализированной онкологии OncoTarget

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

 

Marina I. Sekacheva, MD, PhD, DMSc, Professor, Director of the Institute of personalized medicine, Head of the center for personalized оncology OncoTarget

8/2, Trubetskaya str., Moscow, 119991

https://orcid.org/0000-0002-0658-9130РусановА. С.RusanovA. S.

Русанов Александр Сергеевич, клинический ординатор кафедры онкологии, радиотерапии и пластической хирургии 

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

Alexander S. Rusanov, clinical resident, Department of Oncology, Radiotherapy and Plastic Surgery

8/2, Trubetskaya str., Moscow, 119991

+7 (926) 076-29-69

alexrus146@yandex.ruhttps://orcid.org/0000-0002-5004-8307ФатьяноваА. С.FatyanovaA. S.

Фатьянова Анастасия Сергеевна, канд. мед. наук, доцент кафедры онкологии, радиотерапии и пластической хирургии 

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

Anastasia S. Fatyanova, MD, PhD, Associate Professor, Department of Oncology, Radiotherapy and Plastic Surgery

8/2, Trubetskaya str., Moscow, 119991

https://orcid.org/0000-0002-4196-6042БородаА. М.BorodaA. M.

Борода Александр Моисеевич, научный сотрудник Центра персонализированной онкологии OncoTarget 

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

Alexander M. Boroda, researcher of the center for personalized оncology OncoTarget

8/2, Trubetskaya str., Moscow, 119991

https://orcid.org/0000-0003-0222-2910ИстрановА. Л.IstranovA. L.

Истранов Андрей Леонидович, д-р мед. наук, профессор кафедры онкологии, радиотерапии и пластической хирургии 

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

Andrey L. Istranov, MD, PhD, DMSc, Professor, Department of Oncology, Radiotherapy and Plastic Surgery

8/2, Trubetskaya str., Moscow, 119991

https://orcid.org/0000-0003-3968-6401РусановС. Н.RusanovS. N.

Русанов Сергей Николаевич, д-р мед. наук, профессор кафедры безопасности жизнедеятельности и медицины катастроф 

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

Sergey N. Rusanov, MD, PhD, DMSc, Professor, Department of life safety and disaster medicine

8/2, Trubetskaya str., Moscow, 119991

https://orcid.org/0000-0003-2170-7286БабаеваЮ. В.BabayevaYu. V.

Бабаева Юлия Викторовна, канд. мед. наук, доцент кафедры онкологии, радиотерапии и пластической хирургии 

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

Yulia V. Babayeva, MD, PhD, Associate Professor, Department of Oncology, Radiotherapy and Plastic Surgery

8/2, Trubetskaya str., Moscow, 119991

https://orcid.org/0000-0001-6476-6337ПоддубскаяЕ. В.PoddubskayaE. V.

Поддубская Елена Владимировна, канд. мед. наук, заместитель директора клинического центра по онкологии 

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991

Elena V. Poddubskaya, MD, PhD, Deputy Director of the clinical center for оncology

8/2, Trubetskaya str., Moscow, 119991

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияSechenov First Moscow State Medical University (Sechenov University)Russian Federation202006122020112Special Issue: COVID-196273Copyright © Sekacheva M.I., Rusanov A.S., Fatyanova A.S., Boroda A.M., Istranov A.L., Rusanov S.N., Babayeva Y.V., Poddubskaya E.V., 20202020Секачева М.И., Русанов А.С., Фатьянова А.С., Борода А.М., Истранов А.Л., Русанов С.Н., Бабаева Ю.В., Поддубская Е.В.Sekacheva M.I., Rusanov A.S., Fatyanova A.S., Boroda A.M., Istranov A.L., Rusanov S.N., Babayeva Y.V., Poddubskaya E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sechenovmedj.com/jour/article/view/242

Novel coronavirus infection, causing COVID-19, is not fully controlled for today. In periodicals, there are often reports of a high risk of severe complications in cancer patients during the development of COVID-19. The review presents information from literary sources based on the experience gained in overcoming this formidable disease and its consequences using the examples of foreign colleagues of clinicians, as well as domestic experience and recommendations for the treatment of cancer during the pandemic COVID-19 of the National Medical Research Center for Radiology of the Ministry of Health of Russia with the participation and support of the Association of Oncologists of Russia and the Association of Health Organizers in Oncology. The information is based on actual data collected through the search of sources in abstract and sciencemetric electronic databases, open access resources in Russian and English. The review presents recommendations from international and domestic professional communities regarding the routing and multidisciplinary treatment of cancer patients during the pandemic period.

Новая коронавирусная инфекция, вызывающая COVID-19, на сегодня не в полной мере поддается должному контролю. В периодических изданиях часто появляются сообщения о высоком риске тяжелых осложнений у онкологических пациентов при развитии COVID-19. В обзоре представлены сведения из литературных источников, основанных на полученном опыте преодоления этого грозного заболевания и его последствий на примерах зарубежных коллег клиницистов, а также отечественный опыт и рекомендации по лечению онкологических заболеваний во время пандемии COVID-19 Национального медицинского исследовательского центра радиологии Минздрава России при участии и поддержке Ассоциации онкологов России и Ассоциации организаторов здравоохранения в онкологии. Информация базируется на фактических данных, собранных посредством поиска источников в реферативных и наукометрических электронных базах данных, ресурсах открытого доступа на русском и английском языках. В обзоре представлены рекомендации международных и отечественных профессиональных сообществ относительно маршрутизации и мультидисциплинарного лечения пациентов с онкологическими заболеваниями в период пандемии.

COVID-19группы рискавнутрибольничная инфекциялетальностьонкоскринингвременные схемы леченияхимиотерапиялучевая терапияCOVID-19risk groupshospital-acquired infectionfatality rateoncological screeningtemporary treatment regimenschemotherapyradiotherapyReferencesWorld Health Organization Virtual press conference on COVID-19 — 11 March 2020. URL: https://www.who.int/docs/ default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020. pdf?sfvrsn=cb432bb3_2, free (accessed 06.04.2020).World Health Organization Virtual press conference on COVID-19 — 11 March 2020. URL: https://www.who.int/docs/ default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020. pdf?sfvrsn=cb432bb3_2, free (accessed 06.04.2020).Vremennye metodicheskie rekomendatsii Minzdrava Rossii “Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19)”. Versiia 7 (03.06.2020). [Temporary guidelines of the Ministry of health of the Russian Federation “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)”. Version 7 (03.06.2020)]. (In Russian). URL: http://www.consultant.ru/document/cons_doc_LAW_354163/#dst0, free (accessed 06.06.2020).Временные методические рекомендации Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 7 (03.06.2020). URL: http:// www.consultant.ru/document/cons_doc_LAW_354163/#dst0, свободный. Дата обращения: 06.06.2020.Kamboj M., Sepkowitz K.A. Nosocomial infections in patients with cancer. Lancet Oncol. 2009; 10(6): 589–97. https://doi. org/10.1016/S1470-2045(09)70069-5 PMID: 19482247Kamboj M., Sepkowitz K.A. Nosocomial infections in patients with cancer. Lancet Oncol. 2009; 10(6): 589–97. https://doi. org/10.1016/S1470-2045(09)70069-5 PMID: 19482247Liang W. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3): 335–7. https://doi. org/10.1016/S1470-2045(20)30096-6 PMID: 32066541Liang W. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3): 335–7. https://doi. org/10.1016/S1470-2045(20)30096-6 PMID: 32066541ESMO. ESMO COVID-19 and cancer. URL: https://www. esmo.org/covid-19-and-cancer/q-a-on-covid-19, free (accessed 20.04.2020).ESMO. ESMO COVID-19 and cancer. URL: https://www. esmo.org/covid-19-and-cancer/q-a-on-covid-19, free (accessed 20.04.2020).Gosain R., Abdou Y., Singh A., et al. COVID-19 and cancer: a comprehensive review. current oncology reports 2020 May 8; 22(5): 53. https://doi.org/10.1007/s11912-020-00934-7 PMID: 32385672Gosain R., Abdou Y., Singh A., et al. COVID-19 and cancer: a comprehensive review. current oncology reports 2020 May 8; 22(5): 53. https://doi.org/10.1007/s11912-020-00934-7 PMID: 32385672Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). 16–24 February 2020. https://www.who.int/ docs/default-source/coronaviruse/who-china-joint-mission-oncovid-19-final-report.pdf, free (accessed 22.03.2020).Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). 16–24 February 2020. https://www.who.int/ docs/default-source/coronaviruse/who-china-joint-mission-oncovid-19-final-report.pdf, free (accessed 22.03.2020).Yu J., Ouyang W., Chua M.L.K., Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020 Mar 25; 6(7): 1108–10. https://doi. org/10.1001/jamaoncol.2020.0980 PMID: 32211820Yu J., Ouyang W., Chua M.L.K., Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020 Mar 25; 6(7): 1108–10. https://doi. org/10.1001/jamaoncol.2020.0980 PMID: 32211820The Novel Coronavirus Pneumonia Emergency Response Epide miology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. 2020 Feb 10; 41(2): 145–51. https://doi.org/10.3760/cma .j.issn.0254-6450.2020.02.003 PMID: 32064853 URL: https:// slma.lk/wp-content/uploads/2020/02/TheEpidemiologicalChara cteristicsofanOutbreakof2019NovelCoronavirusDiseases28COVID-1929E28094China2C20201.pdf, free (accessed 22.03.2020).The Novel Coronavirus Pneumonia Emergency Response Epide miology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. 2020 Feb 10; 41(2): 145–51. https://doi.org/10.3760/cma .j.issn.0254-6450.2020.02.003 PMID: 32064853 URL: https:// slma.lk/wp-content/uploads/2020/02/TheEpidemiologicalChara cteristicsofanOutbreakof2019NovelCoronavirusDiseases28COVID-1929E28094China2C20201.pdf, free (accessed 22.03.2020).Desai A., Sachdeva S., Parekh T., Desai R. COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol. 2020 Apr; 6:557–9. https://doi.org/10.1200/GO.20.00097 PMID: 32250659Desai A., Sachdeva S., Parekh T., Desai R. COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol. 2020 Apr; 6:557–9. https://doi.org/10.1200/GO.20.00097 PMID: 32250659Emami A., Javanmardi F., Pirbonyeh N., Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020 Mar 24; 8(1): e35. eCollection. https://doi.org/10.22037/ aaem.v8i1.600 PMID: 32232218Emami A., Javanmardi F., Pirbonyeh N., Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020 Mar 24; 8(1): e35. eCollection. https://doi.org/10.22037/ aaem.v8i1.600 PMID: 32232218Hu Y., Sun J., Dai Z., et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020 Jun; 127: 104371. https://doi.org/10.1016/j. jcv.2020.104371 PMID: 32315817Hu Y., Sun J., Dai Z., et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020 Jun; 127: 104371. https://doi.org/10.1016/j. jcv.2020.104371 PMID: 32315817Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020 Apr 22; 323(20): 2052–9. https://doi.org/10.1001/ jama.2020.6775 PMID: 32320003Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020 Apr 22; 323(20): 2052–9. https://doi.org/10.1001/ jama.2020.6775 PMID: 32320003Grasselli G., Zangrillo A., Zanella A., et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020 Apr 6; 323(16): 1574–81. https://doi.org/10.1001/jama.2020.5394 PMID: 32250385Grasselli G., Zangrillo A., Zanella A., et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020 Apr 6; 323(16): 1574–81. https://doi.org/10.1001/jama.2020.5394 PMID: 32250385Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020 Mar 23; 323(18): 1775–6. https://doi.org/10.1001/ jama.2020.4683 PMID: 32203977Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020 Mar 23; 323(18): 1775–6. https://doi.org/10.1001/ jama.2020.4683 PMID: 32203977Verity R., Okell L.C., Dorigatti I., et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 Jun; 20(6): 669–77. https://doi.org/10.1016/ S1473-3099(20)302 43-7 PMID: 32240634Verity R., Okell L.C., Dorigatti I., et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 Jun; 20(6): 669–77. https://doi.org/10.1016/ S1473-3099(20)30 243-7 PMID: 32240634Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep. ePub: 31 March 2020. 2020 Apr 3; 69(13): 382–6. https://doi.org/10.15585/mmwr.mm6913e2 PMID: 32240123Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep. ePub: 31 March 2020. 2020 Apr 3; 69(13): 382–6. https://doi.org/10.15585/mmwr.mm6913e2 PMID: 32240123Zhang L., Zhu L., Xie C., et al. Clinical characteristics of COVID19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Jul; 31(7): 894–901. https://doi.org/10.1016/j.annonc.2020.03.296 PMID: 32224151Zhang L., Zhu L., Xie C., et al. Clinical characteristics of COVID19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Jul; 31(7): 894–901. https://doi.org/10.1016/j.annonc.2020.03.296 PMID: 32224151Dai M., Liu D., Liu M., et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 2020 Jun; 10(6): 783–91. https://doi.org/10.1158/2159-8290.CD-20-0422 PMID: 32345594Dai M., Liu D., Liu M., et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 2020 Jun; 10(6): 783–91. https://doi.org/10.1158/2159-8290.CD-20-0422 PMID: 32345594Miyashita H., Mikami T., Chopra N., et al. Do Patients with cancer have a poorer prognosis of COVID-19? An experience in New York city. Ann Oncol. 2020 Aug; 31(8): 1088–9. https://doi.org/10.1016/j.annonc.2020.04.006 PMID: 32330541Miyashita H., Mikami T., Chopra N., et al. Do Patients with cancer have a poorer prognosis of COVID-19? An experience in New York city. Ann Oncol. 2020 Aug; 31(8): 1088–9. https://doi.org/10.1016/j.annonc.2020.04.006 PMID: 32330541Mehta V., Goel S., Kabarriti R., et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020 Jul; 10(7): 935–41. https://doi.org/10.1158/2159- 8290.CD-20-0516 PMID: 32357994Mehta V., Goel S., Kabarriti R., et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020 Jul; 10(7): 935–41. https://doi.org/10.1158/2159- 8290.CD-20-0516 PMID: 32357994U.S. Food & Drug Administration. FDA drug shortages. URL: https://www.accessdata.fda.gov/scripts/drugshortages/default. cfm, free (accessed 22.03.2020)U.S. Food & Drug Administration. FDA drug shortages. URL: https://www.accessdata.fda.gov/scripts/drugshortages/default. cfm, free (accessed 22.03.2020)ASCO. ASCO coronavirus resources. URL: https://www.asco. org/asco-coronavirus-information, free (accessed 17.04.2020).ASCO. ASCO coronavirus resources. URL: https://www.asco. org/asco-coronavirus-information, free (accessed 17.04.2020).You B., Ravaud A., Canivet A., et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020 May; 21(5): 619–21. https://doi.org/10.1016/ S1470-2045(20)30204-7 PMID: 32220659You B., Ravaud A., Canivet A., et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020 May; 21(5): 619–21. https://doi.org/10.1016/ S1470-2045(20)30204-7 PMID: 32220659NCCN. Coronavirus disease 2019 (COVID-19) resources for the cancer care community. URL: https://www.nccn.org/covid-19/, free (accessed 12.04.2020).NCCN. Coronavirus disease 2019 (COVID-19) resources for the cancer care community. URL: https://www.nccn.org/covid-19/, free (accessed 12.04.2020).ESMO. ESMO COVID-19 and cancer. URL: https://www.esmo. org/covid-19-and-cancer, free (accessed 20.04.2020).ESMO. ESMO COVID-19 and cancer. URL: https://www.esmo. org/covid-19-and-cancer, free (accessed 20.04.2020).Ontario Health Cancer Care Ontario. Pandemic planning clinical guideline for patients with cancer. URL: https://www.accc-cancer. org/docs/documents/cancer-program-fundamentals/oh-cco-pandemic-planning-clinical-guideline_final_2020-03-10.pdf, free (accessed 20.04.2020).Ontario Health Cancer Care Ontario. Pandemic planning clinical guideline for patients with cancer. URL: https://www.accc-cancer. org/docs/documents/cancer-program-fundamentals/oh-cco-pandemic-planning-clinical-guideline_final_2020-03-10.pdf, free (accessed 20.04.2020).Al-Shamsi H.O., Alhazzani W., Alhuraiji A., et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020 Jun; 25(6): e936–45. https:// doi.org/10.1634/theoncologist.2020-0213 PMID: 32243668Al-Shamsi H.O., Alhazzani W., Alhuraiji A., et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020 Jun; 25(6): e936–45. https:// doi.org/10.1634/theoncologist.2020-0213 PMID: 32243668American Society for Radiation Oncology (ASTRO). COVID-19 recommendations to radiation oncology practices. URL: https:// www.astro.org/Daily-Practice/COVID-19-Recommendationsand-Information, free (accessed 10.05.2020).American Society for Radiation Oncology (ASTRO). COVID-19 recommendations to radiation oncology practices. URL: https:// www.astro.org/Daily-Practice/COVID-19-Recommendationsand-Information, free (accessed 10.05.2020).Kaprin A.D., Kostin A.A., Pashigorova L.V., et al. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19) u onkologicheskikh bol’nykh. Moskva: FGBU “Natsional’nyi meditsinskii issledovatel’skii Tsentr radiologii” Minzdrava Rossii, 2020. 18 р. [Prevention, diagnosis and treatment of new coronavirus infection (COVID-19) in cancer patients]. (In Russian). URL: http://nmicr.ru/news/covid-19/_Covid_брошюра_%20FIN.pdf, (accessed 05.06.2020).Каприн А.Д., Костин А.А., Пашигорова Л.В. и др. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) у онкологических больных. М.: ФГБУ «Национальный медицинский исследовательский Центр радиологии» Минздрава России, 2020. 18 с. URL: http://nmicr. ru/news/covid-19/_Covid_брошюра_%20FIN.pdf (дата обращения: 05.06.2020).Cai Z.X., Wen W.Q., Min Z.J. Comparison of 5–FU-based and capecitabine-based neoadjuvant chemoradiotherapy in patients with rectal cancer: a meta-analysis. Clin Colorectal Cancer. 2017 Sep; 16(3): e123–39. https://doi.org/10.1016/j.clcc.2017.01.009 PMID: 28284574Cai Z.X., Wen W.Q., Min Z.J. Comparison of 5–FU-based and capecitabine-based neoadjuvant chemoradiotherapy in patients with rectal cancer: a meta-analysis. Clin Colorectal Cancer. 2017 Sep; 16(3): e123–39. https://doi.org/10.1016/j.clcc.2017.01.009 PMID: 28284574Willan J., King A.J., Hayes S., et al. Care of haematology patients in a COVID-19 epidemic. Br J Haematol. 2020 Apr; 189(2): 241– 3. https://doi.org/10.1111/bjh.16620 PMID: 32173855Willan J., King A.J., Hayes S., et al. Care of haematology patients in a COVID-19 epidemic. Br J Haematol. 2020 Apr; 189(2): 241– 3. https://doi.org/10.1111/bjh.16620 PMID: 32173855Centers for Disease Control and Prevention. CDC: COVID-19. URL: https://www.cdc.gov/coronavirus/2019-nCoV/index.html, free (accessed 26.04.2020).Centers for Disease Control and Prevention. CDC: COVID-19. URL: https://www.cdc.gov/coronavirus/2019-nCoV/index.html, free (accessed 26.04.2020).American College of Surgeons. ACS: COVID-19 and surgery. URL: https://www.facs.org/covid-19/clinical-guidance, free (accessed 16.04.2020).American College of Surgeons. ACS: COVID-19 and surgery. URL: https://www.facs.org/covid-19/clinical-guidance, free (accessed 16.04.2020).Liang W., Guan W., Chen R., et al. Cancer patients in SARSCoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar; 21(3): 335–7. https://doi.org/10.1016/S1470- 2045(20)30096-6 PMID: 32066541Liang W., Guan W., Chen R., et al. Cancer patients in SARSCoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar; 21(3): 335–7. https://doi.org/10.1016/S1470- 2045(20)30096-6 PMID: 32066541COVID-19 rapid guideline: delivery of systemic anticancer treatments NICE guideline [NG161] Published date: 20 March 2020. Last updated: 27 April 2020. URL: https://www.nice.org.uk/ guidance/ng161/resources/covid19-rapid-guideline-delivery-ofsystemic-anticancer-treatments-pdf-66141895710661, free (accessed 05.05.2020).COVID-19 rapid guideline: delivery of systemic anticancer treatments NICE guideline [NG161] Published date: 20 March 2020. Last updated: 27 April 2020. URL: https://www.nice.org.uk/ guidance/ng161/resources/covid19-rapid-guideline-delivery-ofsystemic-anticancer-treatments-pdf-66141895710661, free (accessed 05.05.2020).Interim treatment change options for the COVID-19 pandemic, endorsed by NHS England (27 April 2020). URL: https://www. nice.org.uk/guidance/ng161/resources/interim-treatment-changeoptions-during-the-covid19-pandemic-endorsed-by-nhs-englandpdf-8715724381, free (accessed 10.05.2020).Interim treatment change options for the COVID-19 pandemic, endorsed by NHS England (27 April 2020). URL: https://www. nice.org.uk/guidance/ng161/resources/interim-treatment-changeoptions-during-the-covid19-pandemic-endorsed-by-nhs-englandpdf-8715724381, free (accessed 10.05.2020).Chua M.L.K. Effektivnyi onkotsentr v epokhu COVID: opyt Kitaia i Singapura [Effective cancer centers in the age of COVID: the experience of China and Singapore]. (In Russian). URL: http://www.protiv-raka.ru/effektivnyj-onkocentr-v-epohu-covidopyt-kitaya-i-singapura/, free (accessed 28.04.2020).Чуа М.Л.К. Эффективный онкоцентр в эпоху COVID: опыт Китая и Сингапура. URL: http://www.protiv-raka.ru/effektivnyjonkocentr-v-epohu-covid-opyt-kitaya-i-singapura/, свободный (дата обращения: 06.06.2020).Snegovoi A.V., Kononenko I.B., Kornietskaia A.L. i dr. Rekomendatsii po profilaktike i lecheniiu neitropenii i anemii u onkopatsientov v period pandemii COVID-19 [Recommendations for the prevention and treatment of neutropenia and anemia in cancer patients during the COVID-19 pandemic]. (In Russian). URL: https://oncology-association.ru/files/pdf/2020/Rekomendacii_ AOR_po_FN_i_anemii.pdf, free (accessed 10.06.2020).Снеговой А.В., Кононенко И.Б., Корниецкая А.Л. и др. Рекомендации по профилактике и лечению нейтропении и анемии у онкопациентов в период пандемии COVID-19. URL: https://oncology-association.ru/files/pdf/2020/Rekomendacii_ AOR_po_FN_i_anemii.pdf, свободный (дата обращения: 10.06.2020).

The authors declare that there are no conflicts of interest present.